Abstract -The antibiotic lincomycin hydrochloride was evaluated for toxicity to larval and adult honey bees and for efficacy in controlling American foulbrood disease (AFB). Results of toxicity studies involving nine applications of lincomycin (200-, 600-, or 1000 mg active ingredient per application) as a dust in confectioners sugar revealed no significant differences in mortality among any of the treatment groups for either adults or larvae, when compared to untreated or sugar-treated controls. In field efficacy studies, 18 colonies with existing oxytetracycline-resistant AFB were dusted three times, one week apart, with either 100-, 200-, or 400 mg lincomycin (in 20 g confectioners sugar). Forty-five days after the third treatment, no visible signs of AFB could be found, regardless of the initial severity of disease or the dose applied.
INTRODUCTION
American foulbrood disease (AFB) is a highly contagious disease of honey bee brood caused by the bacterium Paenibacillus larvae subsp. larvae. The disease is spread in a number of ways including drifting bees and the interchange of contaminated bee equipment between colonies. The disease has been controlled either by the destruction of infected colonies by burning, or by the use of antibiotics. Oxytetracycline hydrochloride (OTC = Terramycin ® ) remains the only approved drug treatment available in the United States for the prevention and control of AFB (see Shimanuki, 1997) . As late as 1993, no difference in sensitivity to OTC could be detected in laboratory disk diffusion assays using P. larvae spores collected prior to and after the introduction of OTC (Shimanuki and Knox, 1994) . However, in 1996 reports from Argentina indicated possible drug resistance (Alippi, 1996) . Since those initial findings, foulbrood resistant to OTC treatment has been documented in the literature (Alippi, 2000; Miyagi et al., 2000) and by our diagnostic service in 24 states (unpublished data).
Laboratory screening of antibiotics indicated that the lincosaminide lincomycin effectively inhibited the growth of OTCresistant P. larvae (Kochansky et al., 2001) . We therefore undertook a study to determine the safety of lincomycin to immature and adult honey bees, and the efficacy of lincomycin against OTC-resistant American foulbrood under field conditions.
MATERIALS AND METHODS

Antibiotic and doses
Lincomycin hydrochloride was purchased commercially as Lincomix ® Soluble Powder (Pharmacia & Upjohn, Kalamazoo MI). All antibiotic treatments were prepared as a dust in 20 g confectioners sugar, and applied across the top bars of frames in the brood chamber. We chose 200 mg lincomycin applied three times, one week apart, as our targeted dose and treatment regime, respectively. The choice of 200 mg lincomycin was based on microbiological assay in which comparable zones of inhibition were observed between lincomycin and OTC (Kochansky et al., 2001) . The treatment regime is similar to that currently used for OTC dust, and results in a total colony exposure of 600 mg antibiotic.
Target animal safety
Colonies and treatments
Twenty queenright colonies with no visible signs of disease and containing no surplus honey were maintained in 2-story, 10-frame Langstroth hives in Beltsville MD. We chose 200 mg lincomycin as our targeted dose, but also examined higher doses (600 mg = 3X; 1000 mg = 5X) for toxicity to bees to fulfill FDA requirements for target animal safety. Therefore, colonies were randomly subdivided into five treatment groups consisting of (1) untreated control (no sugar; no drug); (2) sugar treated control (no drug); (3) 200 mg lincomycin hydrochloride; (4) 600 mg lincomycin hydrochloride; and (5) 1000 mg lincomycin hydrochloride. Each treated group (2-5) received an application every seven days, until a total of nine applications were made. This represents three times what we would consider a normal treatment regime, but was included to meet Food and Drug Administration (FDA) requirements for target animal safety. The study began on July 20, 2000 and was terminated 68 days later on September 25, 2000.
Monitoring adult mortality
Test colonies were maintained on a concrete pad, and an area (0.25 m 2 ) at each colony entrance was marked with indelible crayon. Dead adult bees in the marked area were recorded one-day, four-days and sevendays after each treatment for the duration of the study. After each recording, dead bees were removed from the marked area. During the study, the presence of immature brood was used as an indication of a viable laying queen. At the end of the study, the queen was visually observed.
Monitoring larval mortality
Two areas (100 cells each; approx. 25 cm 2 each) on a frame containing larval bees were marked in every colony immediately prior to the first, fourth and eighth treatment. The number of larvae in each area was recorded and seven days post-treatment, the number of capped cells in each area was used as a measure of toxicity to larval bees. Eighteen days post-treatment, marked areas were inspected for emerging/emerged brood. Due to a dearth of pollen and nectar, all colonies were fed four liters sugar syrup (sugar:water; 2:1) and were given a 300 g pollen patty (pollen:sugar; 4:1) two weeks prior to the eighth treatment, to ensure immature brood for the last portion of the larval toxicity study.
Data analysis
Adults
Counts of dead adult bees (Y) were transformed using log (Y + 1) to remove the dependency of the variance on the mean. ANOVA on the transformed counts were conducted using Proc Mixed (SAS Institute, 1997). Our independent variables were treatment (200, 600, 1000 mg lincomycin; untreated; and sugar-treated), number of days following treatment (one, four, seven), and time of year (seasonal). For these analyses, various repeated measures covariance structures were estimated, with colony as the repeated measure. A compound symmetric covariance structure was preferred on both AIC and BIC measures (see SAS Institute, 1997). Power analysis was performed using the repeated measures module of the Pass 2000 software (Pass, 2000) .
Larvae
The proportions of larvae sealed seven days post-treatment relative to the number of initial larvae marked were transformed using a standard arcsine transformation (sine -1 (square root of Y)). An ANOVA of the transformed proportions was run using Proc Mixed (SAS, 1997). Our independent variables were treatment (200, 600, 1000 mg lincomycin; untreated; and sugar-treated) and time of year (seasonal, i.e. beginning, middle and end of study). As with adults, we used a repeated measures compound symmetric covariance structure, with colony as the repeated measure.
Field efficacy
Colonies and treatments
A quarantine apiary was established in Pennsville NJ, consisting of 19 colonies with visible AFB. These colonies were previously treated by the owner with Terramycin® patties earlier in the year, but remained resistant to treatment. Comb samples from all colonies were subsequently tested in Beltsville MD by disk diffusion and indicated resistant P. larvae.
Colonies were scored as to their degree of disease similar to Hitchcock et al. (1970) . The disease was considered "light", if fewer than 10 diseased cells per colony were found; "moderate", if 11-100 diseased cells per colony were found; and "severe", if greater than 100 diseased cells were found per colony. Based on this scoring system, four colonies were considered "light", six colonies "moderate", and nine, "severe". Colonies were dusted with lincomycin in 20 g confectioners sugar three times, one week apart, in doses of either 100 mg, 200 mg or 400 mg active ingredient per application. This represents the targeted dose (200 mg), and additional doses (one-half the targeted dose and twice the targeted dose) required by FDA for antibiotic efficacy studies. Table I presents the individual doses administered to the colonies in our study. Colonies were re-scored with regard to their disease rating prior to the third treatment and subsequently evaluated 45-days after the third treatment. Colonies in which there were no visible signs of new disease at this time were considered recovered.
Data analysis
The number of colonies rated as either "diseased" or "recovered" (no disease) at the beginning and end of the study was analyzed using a 2 × 2 contingency table and chi-square.
RESULTS
Target animal safety
The average mortality of adult and larval honey bees treated with various doses of lincomycin in a sugar dust is summarized in Table II . ANOVA of the individual transformed data (not shown) revealed no differences in mortality among any of the treatment groups for either adults (p > 0.15) or larvae (p > 0.45). For adults, there was no significant difference in mortality (p > 0.09) on the number of days following treatment (one, four, or seven days after treatment). While there was a significant seasonal effect (counts of dead bees increased with time over the course of the study) for both adults (p < 0.0001) and larvae (p < 0.0001), this was not attributable to the treatments, as there were no significant interaction effects (all p > 0.05). The power analysis of the treatment effect for adults was estimated at 97%. Due to the smaller larval sample size, the power on the test of treatment effects for larvae was only 60%. However, the Hitchcock et al. (1970) . See "Materials and Methods" (Sect. 2.3.1). 3.1 ± 0.3 2.8 ± 0.4 4.7 ± 0.5 4.1 ± 0.5 5.7 ± 0.7 % Larval 3 mortality 6.3 ± 0.8 9.5 ± 1.2 6.7 ± 1.5 6.6 ± 1.1 6.7 ± 0.9 treatment p-value is so large (p > 0.45), it is reasonable to conclude there is no significant treatment effect. All inspections for emerged or emerging bees eighteen days post treatment in the larval portion of this study revealed no abnormalities.
No queens were superseded during the study as all marked queens were accounted for when the study was terminated.
Field efficacy
The ability of lincomycin to control AFB in colonies infected with OTC-resistant P. larvae is summarized in Table III . Nineteen colonies with varying degrees of AFB were dusted with different doses of lincomycin. One colony with "severe" disease was found to be queenless one week into the study and was removed. Of the eighteen remaining colonies, most showed marked signs of improvement after two treatments. At this rating time, only two colonies, one scored "severe", the other scored "moderate", remained in their initial groups. All other colonies improved their score. None of the eighteen colonies showed any visible signs of disease when examined 45-days after the last treatment, regardless of the dose of lincomycin received (p < 0.001; chi-square).
DISCUSSION
While different cultural methods have been proposed for controlling AFB (see Shimanuki, 1997; Van Eaton, 2000) , as well as breeding hygienic bees that diligently remove AFB-infected larvae (Spivak and Gilliam, 1998; Spivak and Reuter, 1998) , antibiotics still remain a valuable tool. We have shown that the lincosaminide antibiotic lincomycin, when applied to honey bee colonies as a dust in confectioners sugar, is effective in controlling OTC-resistant AFB. Colonies with existing AFB and resistant to treatment with Terramycin ® were shown to be free of any disease 45 days after a third dusting with lincomycin. Furthermore, we demonstrated that lincomycin dusts are not toxic to either adult or larval honey bees. This was evident when three-and five-times the envisioned dose was applied to colonies for a period of nine weeks, three-times the envisioned treatment regime. The macrolide antibiotic tylosin also has been shown to be relatively non-toxic to bees and effective in controlling AFB (Hitchcock et al., 1970;  Lincomycin for foulbrood control 551 Peng et al., 1996) , including OTC-resistant strains (Kochansky et al., 2001 ). Both lincomycin and tylosin should play a valuable role in the control of OTC-resistant AFB, as they are structurally dissimilar to each other and to oxytetracycline, thereby reducing the possibility of cross resistance. Lincomycin / Toxizität / AFB-Behandlung
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